Candida albicans

Optimal result: 0 – 0.6 Units

Candida albicans is a filamentous yeast that colonises the mouth and gastrointestinal tract of more than 60% of healthy adults. In immunocompromised subjects (cancer, organ transplants, AIDS) it often causes the infection candidiasis. Superficial infections commonly affect the mouth and vagina, while systemic infections, often together with S. aureus, have a 40-60% mortality rate. C. albicans is associated with small intestinal fungal overgrowth (SIFO), causing bloating, diarrhoea and nausea. C. albicans is also associated with Crohn’s disease.

Candida albicans is a filamentous yeast that colonises the mouth and gastrointestinal tract of more than 60% of healthy adults. In immunocompromised subjects (cancer, organ transplants, AIDS) it often causes the infection candidiasis. Superficial infections commonly affect the mouth and vagina, while systemic infections, often together with S. aureus, have a 40-60% mortality rate. C. albicans is associated with small intestinal fungal overgrowth (SIFO), causing bloating, diarrhoea and nausea. C. albicans is also associated with Crohn’s disease.

Candida albicans is a filamentous yeast that colonises the mouth and gastrointestinal tract of more than 60% of healthy adults. In immunocompromised subjects (cancer, organ transplants, AIDS) it often causes the infection candidiasis. Superficial infections commonly affect the mouth and vagina, while systemic infections, often together with S. aureus, have a 40-60% mortality rate. C. albicans is associated with small intestinal fungal overgrowth (SIFO), causing bloating, diarrhoea and nausea. C. albicans is also associated with Crohn’s disease.

References:

Schulze, J. & Sonnenborn, U. Yeasts in the Gut. Dtsch. Aerzteblatt Online (2009). doi:10.3238/arztebl.2009.0837

Peters, B. M. et al. Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59, 493–503 (2010).

Weinberger, M. et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect. 61, 146–154 (2005).

Erdogan, A. & Rao, S. S. C. Small Intestinal Fungal Overgrowth. Curr. Gastroenterol. Rep. 17, 16 (2015).

Poulain, D. et al. Yeasts: Neglected Pathogens. Dig. Dis. 27, 104–110 (2009).

Candida albicans
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Candida albicans — 10,000+ markers explained
One Candida albicans result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro